Skip to main content
. 2020 Sep 22;123(11):1616–1624. doi: 10.1038/s41416-020-01054-6

Fig. 4. Overall survival stratified by EGFR expression status.

Fig. 4

a Kaplan–Meier estimates in patients without erlotinib treatment by EGFR expression status. b Kaplan–Meier estimates in patients treated with erlotinib by EGFR expression status. HR hazard ratio.